Sugiura W - Search Results

1

Structural Insights into HIV-1 Vif-APOBEC3F Interaction.

Nakashima M, Ode H, Kawamura T, Kitamura S, Naganawa Y, Awazu H, Tsuzuki S, Matsuoka K, Nemoto M, Hachiya A, Sugiura W, Yokomaku Y, Watanabe N, Iwatani Y. Nakashima M, et al. Among authors: sugiura w. J Virol. 2015 Nov 4;90(2):1034-47. doi: 10.1128/JVI.02369-15. Print 2016 Jan 15. J Virol. 2015. PMID: 26537685 Free PMC article.

2

Gag non-cleavage site mutations contribute to full recovery of viral fitness in protease inhibitor-resistant human immunodeficiency virus type 1.

Myint L, Matsuda M, Matsuda Z, Yokomaku Y, Chiba T, Okano A, Yamada K, Sugiura W. Myint L, et al. Among authors: sugiura w. Antimicrob Agents Chemother. 2004 Feb;48(2):444-52. doi: 10.1128/AAC.48.2.444-452.2004. Antimicrob Agents Chemother. 2004. PMID: 14742193 Free PMC article.

3

Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion.

Miyauchi K, Komano J, Yokomaku Y, Sugiura W, Yamamoto N, Matsuda Z. Miyauchi K, et al. Among authors: sugiura w. J Virol. 2005 Apr;79(8):4720-9. doi: 10.1128/JVI.79.8.4720-4729.2005. J Virol. 2005. PMID: 15795258 Free PMC article.

4

Computational simulations of HIV-1 proteases--multi-drug resistance due to nonactive site mutation L90M.

Ode H, Neya S, Hata M, Sugiura W, Hoshino T. Ode H, et al. Among authors: sugiura w. J Am Chem Soc. 2006 Jun 21;128(24):7887-95. doi: 10.1021/ja060682b. J Am Chem Soc. 2006. PMID: 16771502

5

Resistant mechanism against nelfinavir of human immunodeficiency virus type 1 proteases.

Ode H, Ota M, Neya S, Hata M, Sugiura W, Hoshino T. Ode H, et al. Among authors: sugiura w. J Phys Chem B. 2005 Jan 13;109(1):565-74. doi: 10.1021/jp046860+. J Phys Chem B. 2005. PMID: 16851048

6

Mechanism of drug resistance due to N88S in CRF01_AE HIV-1 protease, analyzed by molecular dynamics simulations.

Ode H, Matsuyama S, Hata M, Hoshino T, Kakizawa J, Sugiura W. Ode H, et al. Among authors: sugiura w. J Med Chem. 2007 Apr 19;50(8):1768-77. doi: 10.1021/jm061158i. Epub 2007 Mar 17. J Med Chem. 2007. PMID: 17367119

7

Computational characterization of structural role of the non-active site mutation M36I of human immunodeficiency virus type 1 protease.

Ode H, Matsuyama S, Hata M, Neya S, Kakizawa J, Sugiura W, Hoshino T. Ode H, et al. Among authors: sugiura w. J Mol Biol. 2007 Jul 13;370(3):598-607. doi: 10.1016/j.jmb.2007.04.081. Epub 2007 May 10. J Mol Biol. 2007. PMID: 17524421

8

Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G.

Iwatani Y, Chan DS, Wang F, Stewart-Maynard K, Sugiura W, Gronenborn AM, Rouzina I, Williams MC, Musier-Forsyth K, Levin JG. Iwatani Y, et al. Among authors: sugiura w. Nucleic Acids Res. 2007;35(21):7096-108. doi: 10.1093/nar/gkm750. Epub 2007 Oct 16. Nucleic Acids Res. 2007. PMID: 17942420 Free PMC article.

9

HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain.

Iwatani Y, Chan DS, Liu L, Yoshii H, Shibata J, Yamamoto N, Levin JG, Gronenborn AM, Sugiura W. Iwatani Y, et al. Among authors: sugiura w. Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19539-44. doi: 10.1073/pnas.0906652106. Epub 2009 Nov 3. Proc Natl Acad Sci U S A. 2009. PMID: 19887642 Free PMC article.

10

Structural and energetic analysis on the complexes of clinically isolated subtype C HIV-1 proteases and approved inhibitors by molecular dynamics simulation.

Matsuyama S, Aydan A, Ode H, Hata M, Sugiura W, Hoshino T. Matsuyama S, et al. Among authors: sugiura w. J Phys Chem B. 2010 Jan 14;114(1):521-30. doi: 10.1021/jp908314f. J Phys Chem B. 2010. PMID: 20055526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page